0.35
+12.90%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Telescope Innovations
Its shares trade on Canadian Securities Exchange under the ticker TELI.CN. It has been listed since 27 September 2021. In the fiscal year to 31 August 2025, it reported revenue of C$4.8m and a net loss of C$1.6m. At that date it held total assets of C$7.3m and shareholders' equity of C$2.0m.
Telescope Innovations Corp. Engages in the development and manufacturing of chemical technologies for pharmaceuticals and chemical industries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-09-27. The firm is developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries. The firm builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Its core technology also enables the discovery of novel molecules of therapeutics. Its suite of analytical and automation technologies, including the Direct Inject Liquid Chromatography (DILC) platform for quantitative, online reaction monitoring. DILC is a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. DILC enables unattended sample capture, quenching, dilution, and analysis using a variety of industry standard CDS platforms, including Agilent OpenLab, Agilent ChemStation, Waters Empower 3, and Shimadzu LabSolutions.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 27 Sept 2021
- Website
- telescopeinnovations.com ↗
Leadership
Pay as last reported
- Mr. Ali PejmanIndependent Chairman of the Board
- Prof. Jason HeinChief Executive Officer, Director, since 2021C$200,400
- Mr. Robert ChisholmChief Financial OfficerC$28,500
- Ms. Vaso VlachosChief Operating Officer
- Mr. Henry DubinaIndependent Director
- Mr. Robert MintakIndependent Director
- Dr. James RobinsonIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Telescope Innovations Corp develops scalable manufacturing processes for pharmaceuticals and chemical industries.
- DILC platform enables direct sampling and analysis of chemical reactions with industry standard CDS platforms.
- The company builds flexible robotic platforms and AI software improving experimental throughput and data quality.
Weaknesses
- The company's headquarters in Vancouver, British Columbia, may limit access to global markets.
- Telescope Innovations Corp has no listed competitors in the chemical technology sector.
- The firm's IPO on 27 September 2021 is a recent event with limited market history.
Opportunities
- The pharmaceutical industry's growth in Canada offers new market opportunities for Telescope Innovations Corp.
- The chemical industry's demand for scalable manufacturing processes presents a significant opportunity.
- DILC platform's compatibility with Agilent, Waters, and Shimadzu platforms expands market reach.
Threats
- The chemical technology sector faces increasing regulatory scrutiny from government bodies.
- The pharmaceutical industry's reliance on traditional manufacturing methods poses a threat to new technologies.
- Competition from established players in the chemical technology sector could limit market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.